As Schizophrenia Rivals Rush In, Otsuka and Lundbeck Gain FDA OK for Rexulti

As schizophrenia rivals rush in, Otsuka and Lundbeck gain FDA OK for Rexulti
Otsuka and its partner Lundbeck snagged an FDA approval for Rexulti (brexpiprazole) to treat schizophrenia and as an add-on therapy for major depression, leaving the two companies prepping for an August launch into an increasingly crowded field. The … Read more on FierceBiotech

Veterans Can Get All Of These Prescription Drugs To Treat PTSD, But Not Weed
Many of the medications used to treat serious such as anxiety, depression, flashbacks and insomnia come with risky side effects, especially when combined with one another. One of the … symptoms. It's long, but by no means all-inclusive. Read more on Huffington Post

Tags: , , , ,